Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
Isnardi CA, Cerda OL, Landi M, Cruces L, Schneeberger EE, Montoro CC, Alfaro MA, Roldán BM, Gómez Vara AB, Giorgis P, Ezquer RA, Crespo Rocha MG, Reyes Gómez CR, de Los Ángeles Correa M, Rosemffet MG, Abarza VC, Pellet SC, Perandones M, Reimundes C, Longueira Y, Turk G, Quiroga MF, Laufer N, Quintana R, de la Vega MC, Kreplak N, Pifano M, Maid P, Pons-Estel GJ, Citera G.
Isnardi CA, et al. Among authors: schneeberger ee.
J Rheumatol. 2022 Dec;49(12):1385-1389. doi: 10.3899/jrheum.220469. Epub 2022 Oct 1.
J Rheumatol. 2022.
PMID: 36182107
Free article.